Skip navigation

Regulatory Initiatives - New Formulations – Clinical Trial Strategy

March 27-28, 2019
  • Washington, DC

The R&D and academic communities have developed next-generation pain therapeutics that are both effective and clinically versatile. Join leaders from the biopharma, device and medical communities to learn about the latest breakthroughs in the treatment of various types of pain and network with colleagues from industry, academia, the medical community, government and investors.

This conference provides attendees with thoughtful insight from key industry leaders concerning new formulations, clinical studies and related news from The Hill. Join industry leaders at CBI’s Pharmaceutical Innovations for Pain Management to discuss how to move novel pain therapeutics into a widespread adoption program.

Topics for discussion will include:

  • New Chemical Entities
  • Innovations in Topical Ad Cannabis Therapies
  • Hurtles to Use
  • Transitioning From Opioid Focus Landscape
  • Disease-Focused Targeted Therapies
  • Genotyping for Specific Treatment
  • Targeted and Un-Targeted Therapies

Pharmaceutical Innovations for Pain Management

Regulatory Initiatives - New Formulations – Clinical Trial Strategy

The R&D and academic communities have developed next-generation pain therapeutics that are both effective and clinically versatile. Join leaders from the biopharma, device and medical communities to learn about the latest breakthroughs in the treatment of various types of pain and network with colleagues from industry, academia, the medical community, government and investors.

This conference provides attendees with thoughtful insight from key industry leaders concerning new formulations, clinical studies and related news from The Hill. Join industry leaders at CBI’s Pharmaceutical Innovations for Pain Management to discuss how to move novel pain therapeutics into a widespread adoption program.

Topics for discussion will include:

  • New Chemical Entities
  • Innovations in Topical Ad Cannabis Therapies
  • Hurtles to Use
  • Transitioning From Opioid Focus Landscape
  • Disease-Focused Targeted Therapies
  • Genotyping for Specific Treatment
  • Targeted and Un-Targeted Therapies